IL317182A - Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension - Google Patents
Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertensionInfo
- Publication number
- IL317182A IL317182A IL317182A IL31718224A IL317182A IL 317182 A IL317182 A IL 317182A IL 317182 A IL317182 A IL 317182A IL 31718224 A IL31718224 A IL 31718224A IL 317182 A IL317182 A IL 317182A
- Authority
- IL
- Israel
- Prior art keywords
- hypertension
- rxfp1
- modulators
- heart failure
- treating resistant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263365971P | 2022-06-07 | 2022-06-07 | |
| PCT/EP2023/065045 WO2023237511A1 (en) | 2022-06-07 | 2023-06-06 | Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL317182A true IL317182A (en) | 2025-01-01 |
Family
ID=86851555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL317182A IL317182A (en) | 2022-06-07 | 2023-06-06 | Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20260069558A1 (en) |
| EP (1) | EP4536206A1 (en) |
| JP (1) | JP2025519410A (en) |
| KR (1) | KR20250020502A (en) |
| CN (1) | CN119486724A (en) |
| AU (1) | AU2023284904A1 (en) |
| CA (1) | CA3257296A1 (en) |
| IL (1) | IL317182A (en) |
| MX (1) | MX2024015079A (en) |
| TW (1) | TW202416940A (en) |
| WO (1) | WO2023237511A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260116187A (en) * | 2023-11-17 | 2026-07-28 | 일라이 릴리 앤드 캄파니 | RXFP1 receptor agonist |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9452973B2 (en) | 2012-05-04 | 2016-09-27 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| AU2021395353B2 (en) * | 2020-12-08 | 2024-08-29 | Astrazeneca Ab | 4-(2-fluoro-4-methoxy-5-3-(((1-methylcyclobutyl)methyl)carbamoyl)bicyclo[2.2.1]heptan-2-yl)carbamoyl)phenoxy)-1-methylcyclohexane-1-carboxylic acid derivatives and similar compounds as rxfp1 modulators for the treatment of heart failure |
-
2023
- 2023-06-06 US US18/872,313 patent/US20260069558A1/en active Pending
- 2023-06-06 CA CA3257296A patent/CA3257296A1/en active Pending
- 2023-06-06 WO PCT/EP2023/065045 patent/WO2023237511A1/en not_active Ceased
- 2023-06-06 AU AU2023284904A patent/AU2023284904A1/en active Pending
- 2023-06-06 MX MX2024015079A patent/MX2024015079A/en unknown
- 2023-06-06 TW TW112121119A patent/TW202416940A/en unknown
- 2023-06-06 CN CN202380044988.9A patent/CN119486724A/en active Pending
- 2023-06-06 JP JP2024571318A patent/JP2025519410A/en active Pending
- 2023-06-06 KR KR1020247042965A patent/KR20250020502A/en active Pending
- 2023-06-06 IL IL317182A patent/IL317182A/en unknown
- 2023-06-06 EP EP23731589.0A patent/EP4536206A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3257296A1 (en) | 2023-12-14 |
| MX2024015079A (en) | 2025-01-09 |
| JP2025519410A (en) | 2025-06-26 |
| TW202416940A (en) | 2024-05-01 |
| CN119486724A (en) | 2025-02-18 |
| KR20250020502A (en) | 2025-02-11 |
| AU2023284904A1 (en) | 2025-01-23 |
| US20260069558A1 (en) | 2026-03-12 |
| EP4536206A1 (en) | 2025-04-16 |
| WO2023237511A1 (en) | 2023-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3066017T3 (en) | Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hf-pef) | |
| IL285436A (en) | Composite scaffold for repair, restoration and regeneration of soft tissues | |
| SG11202003971RA (en) | Methods of treating heart failure with reduced ejection fraction with dapagliflozin | |
| CA223415S (en) | Implantable artificial bronchus | |
| IL314157A (en) | Prosthetic heart valves | |
| IL317936A (en) | Prosthetic heart valves | |
| HK40127095A (en) | Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension | |
| MX2024015079A (en) | Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension | |
| ZA202107513B (en) | Compounds and compositions comprising the same for treating hypertension or heart failure | |
| CA224776S (en) | Winch | |
| CA216672S (en) | Dovetail decking panel | |
| HK40065900A (en) | Treating heart failure | |
| ZA202200320B (en) | Method for controlling radix saposhnikoviae root rot or leaf spot caused by alternaria | |
| GB202507839D0 (en) | Heart failure | |
| GB202507142D0 (en) | Peptide for treating heart failure | |
| HK40064736A (en) | Compounds and compositions comprising the same for treating hypertension or heart failure | |
| HK40080740A (en) | Methods of treating pulmonary arterial hypertension | |
| HK40108887A (en) | Methods of reducing the risk of heart failure | |
| EP4326244A4 (en) | Methods of reducing the risk of heart failure | |
| AU2021900882A0 (en) | Treatment methods for pulmonary arterial hypertension | |
| PH32023050513S1 (en) | Yachts | |
| PH32023050512S1 (en) | Yachts | |
| GB202411390D0 (en) | Heart valve commissure bridge for valve repair | |
| GB202314641D0 (en) | Treatment for batten disease | |
| CA3272055A1 (en) | Methods for treating pulmonary hypertension |